ConductScience.org, home

Paper736651

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Balch CM and 5 others. Ann Surg, 1978. Cited by 367 papers, by iCite.

Cite this record

ConductScience Library. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Papers, record 736651. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/736651

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
PubMed
Journal
Ann Surg
PubMed
Year
1978
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
367
iCite
Relative citation ratio, by iCite
11.8
iCite
Revised in PubMed
2023-02-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balch CMC M
2Murad TMT M
3Soong SJS J
4Ingalls ALA L
5Halpern NBN B
6Maddox WAW A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Aged
Factor Analysis, Statistical
Female
Humans
Lymphocytes
Male
Melanins
Middle Aged
Neoplasm Staging
Prognosis

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
214341275A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.Biometrika1965https://conductscience.org/library/papers/14341275PubMed
314313180STAGING OF MALIGNANT MELANOMAS BY DEPTH OF INVASION; A PROPOSED INDEX TO PROGNOSIS.Am J Surg1965https://conductscience.org/library/papers/14313180PubMed
414485771Malignant melanomas of the skin. A study of the origin, development, aetiology, spread, treatment, and prognosis. I.Br J Plast Surg1962https://conductscience.org/library/papers/14485771PubMed
7841450A clinicopathologic study of prognostic factors in cutaneous malignant melanoma.Surg Gynecol Obstet1977https://conductscience.org/library/papers/841450PubMed
8638981A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results.Cancer1978https://conductscience.org/library/papers/638981PubMed
9921357Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma.Ann Surg1977https://conductscience.org/library/papers/921357PubMed
10907393A rational approach to the surgical management of melanoma.Ann Surg1977https://conductscience.org/library/papers/907393PubMed
11895764Inefficacy of immediate node dissection in stage 1 melanoma of the limbs.N Engl J Med1977https://conductscience.org/library/papers/895764PubMed
12889365Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study.Ann Surg1977https://conductscience.org/library/papers/889365PubMed
134423522Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck.Am J Surg1974https://conductscience.org/library/papers/4423522PubMed
141273763Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis.Surgery1976https://conductscience.org/library/papers/1273763PubMed
151190862Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma.Ann Surg1975https://conductscience.org/library/papers/1190862PubMed
161164058Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).Ann Surg1975https://conductscience.org/library/papers/1164058PubMed
175111283Selective regional lymphadenectomy for melanoma: a mathematical aid to clinical judgment.Ann Surg1971https://conductscience.org/library/papers/5111283PubMed
185477666Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.Ann Surg1970https://conductscience.org/library/papers/5477666PubMed
195773814The histogenesis and biologic behavior of primary human malignant melanomas of the skin.Cancer Res1969https://conductscience.org/library/papers/5773814PubMed
205844157Spontaneous regression of primary malignant melanomas with regional metastases.Cancer1965https://conductscience.org/library/papers/5844157PubMed

Download CSV of references

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 367 citations.

PMIDTitleJournalYearIn PapersSource
41920996Tissue-specific inflammation induces cell state plasticity with oncogenic addiction in mucosal melanoma.Sci Adv2026https://conductscience.org/library/papers/41920996PubMed
40941017Melanoma Skin Cancer: A Comprehensive Review of Current Knowledge.Cancers (Basel)2025https://conductscience.org/library/papers/40941017PubMed
40004177Association of Plasma Lipid Patterns and LDL Cholesterol Levels with Breslow Thickness and Ulceration in Melanoma Patients.Int J Mol Sci2025https://conductscience.org/library/papers/40004177PubMed
38626072Could the mitotic count improve personalized prognosis in melanoma patients?PLoS One2024https://conductscience.org/library/papers/38626072PubMed
38410760Immune checkpoint inhibitors in metastatic melanoma therapy (Review).Med Int (Lond)2024https://conductscience.org/library/papers/38410760PubMed
37649946Histopathologic and Molecular Features of Cutaneous Melanoma in a Moroccan Population.Cureus2023https://conductscience.org/library/papers/37649946PubMed
37592896Development and validation of two online dynamic nomograms for patients with non-distant metastatic cutaneous melanoma based on surgical approaches.Cancer Med2023https://conductscience.org/library/papers/37592896PubMed
36060503The prognostic significance of the clinical and histological parameters in primary cutaneous melanoma patients.Med Pharm Rep2022https://conductscience.org/library/papers/36060503PubMed
35770115Value of a Signature of Immune-Related Genes in Predicting the Prognosis of Melanoma and Its Responses to Immune Checkpoint Blocker Therapies.Comput Math Methods Med2022https://conductscience.org/library/papers/35770115PubMed
35601077Histopathological evaluation of cutaneous malignant melanoma: A retrospective study.Exp Ther Med2022https://conductscience.org/library/papers/35601077PubMed
35591818Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness.Arch Med Sci2022https://conductscience.org/library/papers/35591818PubMed
35347700Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3).Br J Dermatol2022https://conductscience.org/library/papers/35347700PubMed
34680222BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics.Cancers (Basel)2021https://conductscience.org/library/papers/34680222PubMed
34631188
A Case of Amelanotic Malignant Melanoma of the Lingual Base That Was Diagnosed Based on a Biopsy of Late Metastasis to a Lumbar Vertebra after Being Misdiagnosed as HPV-Positive Oropharyngeal Anterior Wall Squamous Cell Carcinoma.
Case Rep Otolaryngol2021https://conductscience.org/library/papers/34631188PubMed
32061122Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.J Natl Cancer Inst2020https://conductscience.org/library/papers/32061122PubMed
31602560Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma.Am J Clin Dermatol2020https://conductscience.org/library/papers/31602560PubMed
30651872Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p.Exp Ther Med2019https://conductscience.org/library/papers/30651872PubMed
30232648Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.Curr Treat Options Oncol2018https://conductscience.org/library/papers/30232648PubMed
29912415Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy.J Natl Cancer Inst2019https://conductscience.org/library/papers/29912415PubMed
29641692Prognostic factors for metastasis in cutaneous melanoma.An Bras Dermatol2018https://conductscience.org/library/papers/29641692PubMed

See all 80 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/736651

GET https://conductscience.org/api/papers/v1/736651/cited_by?page=2